On Friday, an Australian court ruled that American biotech company, Myriad Genetics, can patent a human gene linked to an increased risk of breast cancer. The court reasoned that because the gene is created artificially, it can be patented.
A similar gene patent case is pending before the United States Supreme Court: Association for Molecular Pathology v. Myriad Genetics.